Information:
Error:
ID
34554
Description
An Observational Study on The Safety and Effectiveness of Mabthera (Rituximab) in The First Six Months of Treatment in Patients With Severe Active Rheumatoid Arthritis; ODM derived from: https://clinicaltrials.gov/show/NCT01071798
Link
https://clinicaltrials.gov/show/NCT01071798
Keywords
Versions (1)
- 1/19/19 1/19/19 -
Copyright Holder
see on clinicaltrials.gov
Uploaded on
January 19, 2019
DOI
To request one please log in.
License
Creative Commons BY 4.0
Model comments :
You can comment on the data model here. Via the speech bubbles at the itemgroups and items you can add comments to those specificially.
Itemgroup comments for :
Item comments for :
In order to download data models you must be logged in. Please log in or register for free.
Eligibility Rheumatoid Arthritis NCT01071798
Eligibility Rheumatoid Arthritis NCT01071798
- StudyEvent: Eligibility
Similar models
Eligibility Rheumatoid Arthritis NCT01071798
- StudyEvent: Eligibility
Name
Type
Description | Question | Decode (Coded Value)
Data type
Alias
ID.1
Item
adult patients, >/= 18 years of age
boolean
ID.2
Item
severe active rheumatoid arthritis; eligible for treatment with rituximab according to current spc
boolean
ID.3
Item
informed consent to data collection
boolean
ID.4
Item
ongoing contraception (for female patients only)
boolean
ID.5
Item
previous treatment with rituximab (mabthera)
boolean
ID.6
Item
allergy against monoclonal antibodies, respectively chimeric monoclonal antibodies
boolean
ID.7
Item
active severe infection
boolean
ID.8
Item
severe heart failure (nyha class iv) or severe, uncontrolled cardiac disease
boolean
ID.9
Item
treatment in other studies within 3 months before rituximab therapy
boolean
ID.10
Item
pregnancy or breast feeding
boolean